Skip to main content

SeeQ Diagnostics

The SeeQ Diagnostics project is based on scientific research from Professor Mads Albertsen’s group at the Department of Chemistry and Bioscience at Aalborg University. The project aims to develop an agnostic platform for rapid pathogen identification directly from < 1mL of blood.

A key focus for SeeQ Diagnostics at BII is the development of its first product, SepSeeQ, that will enable identification of the causative pathogen in patients suspected of sepsis, bringing the recently published clinical results to market. Infectious sepsis is an area with high medical needs, due to growing antimicrobial resistance in hospitals worldwide, projected to result in >2 mio deaths in 2030, surpassing cancer mortality. Please see www.seeqdiagnostics.com.

Project summary

Purpose
To develop an agnostic platform for rapid pathogen identification directly from a blood sample.
Host university
Aalborg University (AAU)
Funding per year
DKK 6,5M
Duration
Three years
Expected outcome
Viable startup that can raise seed or Series A financing

Project leaders

See who heads the SeeQ project on its mission to develop an agnostic platform for rapid pathogen identification directly from a blood sample.

Other Bio Studio projects

All start-ups and projects
“We are extremely excited to bring the culmination of more than a decade of research within metagenomics to patients, enabling faster precision diagnostics for targeted antimicrobial treatment, for better patient outcomes.”
Anders B. Sørensen Entrepreneur in Residence